receive daily
reports of the
TOP PICKS
OR
your personal
stock choices
| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
|
| There are 5 registered members and 71 guests viewing the site. | Follow us on Twitter |  Rss Top Picks Feed | Rss Daily Feed |
|
| PAST TOP PICK | 26.770 | Gordon Reid | (A Top Pick April 27/11. Down 2.73%.) Contract research for Pharma companies. Very good company. Now going into partnership with large pharmas. | 2012-04-18 | |
| PAST TOP PICK | 26.160 | Gordon Reid | (Top Pick Apr 27/11, Down 5.79%) Clinical trial company. It is an efficient model | 2012-03-14 | |
| TOP PICK | 27.450 | Gordon Reid | Clinical trial management. They take phase 1 drugs and run them through the trials. About a $2.9 billion backlog and a book to bill of about $1.5 billion, meaning that for every $1 they bill, they get orders of $1.50. | 2011-04-27 | |
| PAST TOP PICK | 21.840 | Gordon Reid | (A Top Pick March 11/09. Up 180.8%.) About 60% of revenues come from outside the US. | 2010-03-10 | |
| PAST TOP PICK | 20.350 | Gordon Reid | (Top Pick Mar 11/09, Up 163.6%) Not as cheap as it was, but still good value. | 2010-02-17 | |
| TOP PICK | 7.760 | Gordon Reid | Contract research organization and do drug trials on behalf of pharmaceuticals and biopharmas. Stock has been beaten down on worries of lack of pipeline and foreign exchange worries. | 2009-03-11 | |
| TOP PICK | 25.900 | Gordon Reid | Contract research that does clinical drug trials for major drug companies. Strong growing franchise. | 2008-07-09 |
